Sarosh Rana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sarosh Rana has a total of 271 co-authors. Here are the top co-authors by number of shared publications:
Ariel Mueller
Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, United States
31 shared publicationsEasha Patel
Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, University of Chicago Medical Center, Chicago, IL, USA
12 shared publicationsJoana Lopes Perdigao
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Chicago, Chicago, USA
12 shared publicationsCourtney Bisson
Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, University of Chicago Medical Center, Chicago, IL, USA
10 shared publicationsSunitha Suresh
Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, NorthShore University Health System, IL, United States
8 shared publicationsColleen Duncan
Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, University of Chicago Medical Center, Chicago, IL, USA
7 shared publications
Latest Publications
- 15 July 2025
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 233 (6) , e265
Elevating the real-world utility of sFlt-1/PlGF testing in hypertensive disorders of pregnancy: strengths and considerations
- 15 July 2025
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 233 (6) , e265
Elevating the real-world utility of sFlt-1/PlGF testing in hypertensive disorders of pregnancy: strengths and considerations
- 12 March 2025
- Published by Elsevier in Pregnancy Hypertension
- Vol. 40, 101206
Circulating follistatin-like 3 and its association with postpartum cardiovascular dysfunction and severe maternal morbidity
- 12 March 2025
- Published by Elsevier in Pregnancy Hypertension
- Vol. 40, 101206
Circulating follistatin-like 3 and its association with postpartum cardiovascular dysfunction and severe maternal morbidity
- 29 January 2025
- Published by Elsevier in Pregnancy Hypertension
- Vol. 39, 101199
Effect of postpartum oral furosemide use on postpartum readmissions and blood pressure trends
- 29 January 2025
- Published by Elsevier in Pregnancy Hypertension
- Vol. 39, 101199
Effect of postpartum oral furosemide use on postpartum readmissions and blood pressure trends
- 18 January 2025
- Published by Elsevier in Pregnancy Hypertension
- Vol. 39, 101190
Neonatal cost savings in hypertensive disorders of pregnancy: Economic evaluation of the sFlt-1/PlGF test with real world implementation of biomarkers
- 18 January 2025
- Published by Elsevier in Pregnancy Hypertension
- Vol. 39, 101190
Neonatal cost savings in hypertensive disorders of pregnancy: Economic evaluation of the sFlt-1/PlGF test with real world implementation of biomarkers
- 10 January 2025
- Published by Elsevier in Pregnancy Hypertension
- Vol. 39, 101183
Response to the Letter to the Editor: “Signs or symptoms of suspected preeclampsia – A retrospective National database study of prevalence, costs, and outcomes”
- 10 January 2025
- Published by Elsevier in Pregnancy Hypertension
- Vol. 39, 101183
Response to the Letter to the Editor: “Signs or symptoms of suspected preeclampsia – A retrospective National database study of prevalence, costs, and outcomes”
- 21 December 2024
- Published by Elsevier in Pregnancy Hypertension
- Vol. 39, 101180
Systematic treatment and management of postpartum hypertension using remote patient monitoring
- 21 December 2024
- Published by Elsevier in Pregnancy Hypertension
- Vol. 39, 101180
Systematic treatment and management of postpartum hypertension using remote patient monitoring
- 13 September 2024
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 232 (2) , e71
Real-world evidence for utility of serum angiogenic and antiangiogenic biomarker testing
- 13 September 2024
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 232 (2) , e71
Real-world evidence for utility of serum angiogenic and antiangiogenic biomarker testing
- 10 August 2024
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 232 (2) , e67
Real-world evidence for the utility of serum soluble fms–like tyrosine kinase 1/placental growth factor testing
- 10 August 2024
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 232 (2) , e67
Real-world evidence for the utility of serum soluble fms–like tyrosine kinase 1/placental growth factor testing
- Open Access
- 17 July 2024
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 232 (4) , 385.e1-385.e21
Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy
- 17 July 2024
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 232 (4) , 385.e1-385.e21
Open AccessReal-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy